Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.91%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 4.66Close
$ 2.07 - $ 7.08 52-Week Range
Ticker Information
Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQEVOKE PHARMA INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EVOK - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 500K | 3.91% | $ 12.79M |
| 3/31/2025 | $ 500K | 4.31% | $ 11.59M |
| 12/31/2024 | $ 501.37K | 4.89% | $ 10.25M |
| 9/30/2024 | $ 501.37K | 5.82% | $ 8.62M |
| 6/30/2024 | $ 501.37K | 6.66% | $ 7.53M |
| 3/31/2024 | $ 501.37K | 8.21% | $ 6.11M |
| 12/31/2023 | $ 500K | 9.65% | $ 5.18M |
| 9/30/2023 | $ 500K | 11.63% | $ 4.3M |
| 6/30/2023 | $ 500K | 14% | $ 3.57M |
| 3/31/2023 | $ 500K | 17.24% | $ 2.9M |
Key Performance Insights, Last 5 Years
- EVOKE PHARMA INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, EVOKE PHARMA INC's average Int. Exp. % has been 55.02%.
- The median Int. Exp. % for EVOKE PHARMA INC during this period was 17.24%
- EVOKE PHARMA INC reached its highest Int. Exp. % over the past 5 years at 490.85%.
- The lowest Int. Exp. % recorded by EVOKE PHARMA INC in the same timeframe 3.91%
EVOKE PHARMA INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for EVOKE PHARMA INC is calculated as follows: Int. Exp. [ $ 53.44K ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] EVOK - Interest Expense Margin, Last 5 years
3.91%
Minimum
Jun 30, 2025
490.85%
Maximum
Dec 31, 2020
55.02%
Average
17.24%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |